Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Shih

Showing results (541-550 of 615) with videos related to

Pageof 62
Sort By:
Cancer Discovery|February 15, 2017
Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in <i>IDH2</i>- and <i>TET2</i>-Mutant Acute Myeloid LeukemiaAlan H Shih, Cem Meydan, Kaitlyn Shank, et al.
The New England Journal of Medicine|March 5, 2020
MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer DiagnosisMichael Ahdoot, Andrew R Wilbur, Sarah E Reese, et al.
Clinical Immunology (Orlando, Fla.)|October 1, 2014
Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphomaJonathan L Berkowitz, John E Janik, Donn M Stewart, et al.
Oncogene|August 1, 2017
EZH2-mediated upregulation of ROS1 oncogene promotes oral cancer metastasisC-H Shih, Y-J Chang, W-C Huang, et al.
Oncotarget|February 1, 2019
A comparison of prostate cancer bone metastases on <sup>18</sup>F-Sodium Fluoride and Prostate Specific Membrane Antigen (<sup>18</sup>F-PSMA) PET/CT: Discordant uptake in the same lesionStephanie A Harmon, Esther Mena, Joanna H Shih, et al.
Plos Computational Biology|April 22, 2025
Learning and teaching biological data science in the Bioconductor communityJenny Drnevich, Frederick J Tan, Fabricio Almeida-Silva, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 2018
A Prospective Comparison of <sup>18</sup>F-Sodium Fluoride PET/CT and PSMA-Targeted <sup>18</sup>F-DCFBC PET/CT in Metastatic Prostate CancerStephanie A Harmon, Ethan Bergvall, Esther Mena, et al.
European Radiology|April 14, 2018
Computer-aided diagnosis prior to conventional interpretation of prostate mpMRI: an international multi-reader studyMatthew D Greer, Nathan Lay, Joanna H Shih, et al.
Academic Radiology|March 8, 2020
Quality of Prostate MRI: Is the PI-RADS Standard Sufficient?Jonathan Sackett, Joanna H Shih, Sarah E Reese, et al.
The Journal of Urology|July 28, 2020
PI-RADS® Category as a Predictor of Progression to Unfavorable Risk Prostate Cancer in Men on Active SurveillanceAlex Z Wang, Luke P O’Conno, Nitin K Yerram, et al.
Pageof 62

Showing results (541-550 of 615) with videos related to

Sort By:
Pageof 62
Cancer Discovery|February 15, 2017
Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in <i>IDH2</i>- and <i>TET2</i>-Mutant Acute Myeloid LeukemiaAlan H Shih, Cem Meydan, Kaitlyn Shank, et al.
The New England Journal of Medicine|March 5, 2020
MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer DiagnosisMichael Ahdoot, Andrew R Wilbur, Sarah E Reese, et al.
Clinical Immunology (Orlando, Fla.)|October 1, 2014
Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphomaJonathan L Berkowitz, John E Janik, Donn M Stewart, et al.
Oncogene|August 1, 2017
EZH2-mediated upregulation of ROS1 oncogene promotes oral cancer metastasisC-H Shih, Y-J Chang, W-C Huang, et al.
Oncotarget|February 1, 2019
A comparison of prostate cancer bone metastases on <sup>18</sup>F-Sodium Fluoride and Prostate Specific Membrane Antigen (<sup>18</sup>F-PSMA) PET/CT: Discordant uptake in the same lesionStephanie A Harmon, Esther Mena, Joanna H Shih, et al.
Plos Computational Biology|April 22, 2025
Learning and teaching biological data science in the Bioconductor communityJenny Drnevich, Frederick J Tan, Fabricio Almeida-Silva, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 2018
A Prospective Comparison of <sup>18</sup>F-Sodium Fluoride PET/CT and PSMA-Targeted <sup>18</sup>F-DCFBC PET/CT in Metastatic Prostate CancerStephanie A Harmon, Ethan Bergvall, Esther Mena, et al.
European Radiology|April 14, 2018
Computer-aided diagnosis prior to conventional interpretation of prostate mpMRI: an international multi-reader studyMatthew D Greer, Nathan Lay, Joanna H Shih, et al.
Academic Radiology|March 8, 2020
Quality of Prostate MRI: Is the PI-RADS Standard Sufficient?Jonathan Sackett, Joanna H Shih, Sarah E Reese, et al.
The Journal of Urology|July 28, 2020
PI-RADS® Category as a Predictor of Progression to Unfavorable Risk Prostate Cancer in Men on Active SurveillanceAlex Z Wang, Luke P O’Conno, Nitin K Yerram, et al.
Pageof 62